Opioid agonist treatment in the time of fentanyl: What can we learn from emerging evidence?

Research output: Contribution to journalComment / DebateOtherpeer-review

Original languageEnglish
Number of pages2
JournalDrug and Alcohol Review
DOIs
Publication statusAccepted/In press - 9 Jan 2020

Keywords

  • Opioid agonist treatment
  • fentanyl
  • buprenorphine
  • Opioid-related disorder

Cite this

@article{19b044cbd071437885dd204ac3e361a6,
title = "Opioid agonist treatment in the time of fentanyl: What can we learn from emerging evidence?",
keywords = "Opioid agonist treatment, fentanyl, buprenorphine, Opioid-related disorder",
author = "Shalini Arunogiri and Suzanne Nielsen",
year = "2020",
month = "1",
day = "9",
doi = "10.1111/dar.13029",
language = "English",
journal = "Drug and Alcohol Review",
issn = "0959-5236",
publisher = "Wiley-Blackwell",

}

Opioid agonist treatment in the time of fentanyl : What can we learn from emerging evidence? / Arunogiri, Shalini; Nielsen, Suzanne.

In: Drug and Alcohol Review, 09.01.2020.

Research output: Contribution to journalComment / DebateOtherpeer-review

TY - JOUR

T1 - Opioid agonist treatment in the time of fentanyl

T2 - What can we learn from emerging evidence?

AU - Arunogiri, Shalini

AU - Nielsen, Suzanne

PY - 2020/1/9

Y1 - 2020/1/9

KW - Opioid agonist treatment

KW - fentanyl

KW - buprenorphine

KW - Opioid-related disorder

U2 - 10.1111/dar.13029

DO - 10.1111/dar.13029

M3 - Comment / Debate

JO - Drug and Alcohol Review

JF - Drug and Alcohol Review

SN - 0959-5236

ER -